Cardiovascular Systems Financial Statements ()
|
|
|
|
Report date
|
|
|
30.06.2022 |
18.08.2022 |
30.09.2022 |
03.11.2022 |
09.02.2023 |
|
09.02.2023 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
0.062 |
62.5 |
0.060 |
59.7 |
61.5 |
|
183.7 |
|
Operating Income, bln rub |
|
|
-0.009 |
-9.49 |
-0.011 |
-10.9 |
-8.53 |
|
-28.9 |
|
EBITDA, bln rub |
? |
|
-0.008 |
-9.14 |
-0.009 |
-9.02 |
-8.18 |
|
-26.4 |
|
Net profit, bln rub |
? |
|
-0.010 |
-9.69 |
-0.011 |
-10.6 |
-7.89 |
|
-28.2 |
|
|
OCF, bln rub |
? |
|
0.000 |
-9.83 |
0.000 |
-13.7 |
-3.55 |
|
-27.0 |
|
CAPEX, bln rub |
? |
|
0.000 |
1.000 |
0.000 |
0.688 |
2.04 |
|
3.73 |
|
FCF, bln rub |
? |
|
0.000 |
-10.8 |
0.000 |
-14.3 |
-5.59 |
|
-30.8 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
|
OPEX, bln rub |
|
|
0.055 |
55.7 |
0.054 |
53.9 |
51.5 |
|
161.2 |
|
Cost of production, bln rub |
|
|
0.016 |
16.3 |
0.017 |
16.7 |
18.5 |
|
51.4 |
|
R&D, bln rub |
|
|
0.009 |
8.77 |
0.009 |
9.06 |
9.53 |
|
27.4 |
|
Interest expenses, bln rub |
|
|
0.000 |
0.407 |
0.000 |
0.406 |
0.404 |
|
1.22 |
|
|
Assets, bln rub |
|
|
0.323 |
322.7 |
0.312 |
312.0 |
311.5 |
|
311.5 |
|
Net Assets, bln rub |
? |
|
0.249 |
249.5 |
0.242 |
242.2 |
239.4 |
|
239.4 |
|
Debt, bln rub |
|
|
0.000 |
20.3 |
0.000 |
21.4 |
20.1 |
|
20.1 |
|
Cash, bln rub |
|
|
0.160 |
159.8 |
0.144 |
143.7 |
132.0 |
|
132.0 |
|
Net debt, bln rub |
|
|
-0.16 |
-139.5 |
-0.14 |
-122.3 |
-111.9 |
|
-111.9 |
|
|
Ordinary share price, rub |
|
|
14.4 |
14.4 |
13.9 |
13.9 |
13.6 |
|
13.6 |
|
Number of ordinary shares, mln |
|
|
39.3 |
39.3 |
39.6 |
39.6 |
39.7 |
|
39.7 |
|
|
Market cap, bln rub |
|
|
565 |
565 |
549 |
549 |
540 |
|
540 |
|
EV, bln rub |
? |
|
565 |
425 |
549 |
427 |
428 |
|
428 |
|
Book value, bln rub |
|
|
0 |
234 |
0 |
227 |
224 |
|
224 |
|
|
EPS, rub |
? |
|
0.00 |
-0.25 |
0.00 |
-0.27 |
-0.20 |
|
-0.71 |
|
FCF/share, rub |
|
|
0.00 |
-0.28 |
0.00 |
-0.36 |
-0.14 |
|
-0.78 |
|
BV/share, rub |
|
|
0.01 |
5.94 |
0.01 |
5.73 |
5.66 |
|
5.66 |
|
|
EBITDA margin, % |
? |
|
-13.5% |
-14.6% |
-15.7% |
-15.1% |
-13.3% |
|
-14.3% |
|
Net margin, % |
? |
|
-15.5% |
-15.5% |
-17.8% |
-17.8% |
-12.8% |
|
-15.4% |
|
FCF yield, % |
? |
|
-1.01% |
-3.44% |
-2.50% |
-5.12% |
-6.23% |
|
-5.69% |
|
ROE, % |
? |
|
-14 935% |
-18.8% |
-11 983% |
-16.4% |
-19.9% |
|
-11.8% |
|
ROA, % |
? |
|
-11 547% |
-14.5% |
-9 299% |
-12.7% |
-15.3% |
|
-9.06% |
|
|
P/E |
? |
|
-15.2 |
-12.0 |
-18.9 |
-13.8 |
-11.4 |
|
-19.1 |
|
P/FCF |
|
|
|
-29.0 |
|
-19.5 |
-16.0 |
|
-17.6 |
|
P/S |
? |
|
2.45 |
1.93 |
3.14 |
2.34 |
1.82 |
|
2.94 |
|
P/BV |
? |
|
2 417 |
2.42 |
2 421 |
2.42 |
2.41 |
|
2.41 |
|
EV/EBITDA |
? |
|
-16.8 |
-10.0 |
-21.5 |
-11.5 |
-9.47 |
|
-16.3 |
|
Debt/EBITDA |
|
|
0.00 |
3.29 |
0.01 |
3.30 |
2.47 |
|
4.25 |
|
|
R&D/CAPEX, % |
|
|
|
877.3% |
|
1 316% |
467.5% |
|
734.4% |
|
|
CAPEX/Revenue, % |
|
|
0.00% |
1.60% |
0.00% |
1.15% |
3.32% |
|
2.03% |
|
| Cardiovascular Systems shareholders |
